Strengthening voluntary non-remunerated plasma collection capacity in Europe
About Us
What is SUPPLY?
SUPPLY is a project co-funded by the European Union’s EU4Health Programme that aims to increase and strengthen the resilience of plasma collection in the EU to enable a stable and adequate supply of Plasma-derived medicinal products (PDMPs). The entire plasma chain is assessed – from plasma donor recruitment, retention, and health, through plasma collection and processing, to demand and use of PDMPs.
Now is the time…
..for policymakers, healthcare providers, and stakeholders to consider the guidance provided and work collaboratively to achieve optimal availability of plasma medicines for patients.
..to examine the recommendations provided in SUPPLY to increase plasma collection in the EU by the public health sector to ensure a sufficient, adequate, and resilient supply of plasma and to contribute to European self-sufficiency.
..to review the recommendations and guidance provided and implement the measures required to ensure the plasma and PDMP system is robust and resilient now and in the next times of crisis.
..to act in the interests of patients, donors, and all EU citizens.
Key Take-Aways
- Focus on retaining donors while building a sustainable donor base
- Carry out a large prospective study in plasma donors to examine the health consequences of plasma donation at varying frequencies
- Take consideration of the IgG level to determine the value of plasma
- Invest in the increase and improvement of the plasma collection – EU Member States, create action plans!
- Introduce legal provisions at national level which link collected plasma to the usage of products manufactured from this plasma by the public health sector
- Create national databases on Ig usage at patient level
- Need for an EU wide harmonized management plan on shortages
- Continue to collaborate!
Who are we?
The SUPPLY project, led by the European Blood Alliance, was carried out by a large European consortium of 13 Beneficiaries and 6 Associated Partners with broad and complementary expertise relating to all aspects of blood and plasma collection, processing, and medicinal use.
Latest News
SUPPLY’s impact continues
Two linked articles have just been published in Vox Sanguinis showing that dependence on US Plasma can be offset by publicly collected plasma, which may be converted into PDMPs under contracts that return the products to the public health system. Achieving strategic...
Balancing donor health and plasma collection: Publication
August 21, 2024 Our SUPPLY WP5 Team has published Balancing donor health and plasma collection: a systematic review of the impact of plasmapheresis frequency in Transfusion Medicine Reviews. Recognising that donor protection is essential, the team shows that more...
SUPPLY at ISBT Congress, Barcelona
June 27, 2024 It was fantastic to have multiple presentations from our SUPPLY teams throughout the ISBT Congress in Barcelona, particularly during the Plasma sessions – the emphasis on both patient and donor health was paramount!
SUPPLY at SoHO Conference, Brussels
June 24, 2024 The Supply Project was presented and discussed during the Conference on the new Regulation on Substances of Human Origin (SoHO Regulation) in Brussels. The conference brought together professionals, patients, donors, stakeholders, authorities, and policy...
Incentives for Plasma Donation: Publication
May 7, 2024 Our SUPPLY WP2 Team has published ‘Incentives for plasma donation’ in Vox Sanguinis. The work provides an overview of the incentives used for plasma donation in Europe and beyond and can provide new ideas to blood establishments. Congratulations to Elena...